Virginia Regulatory Town Hall
Agency
Department of Health Professions
Board
Board of Medicine
chapter
Regulations Governing Prescribing of Opioids and Buprenorphine [18 VAC 85 ‑ 21]
Action:
Waiver for e-prescribing of an opioid
Action 5355
 
General Information
Action Summary Section 21 is added to Chapter 21 to: 1) reiterate the requirement that takes effect on July 1, 2020 that a prescription for a controlled substance that contains an opioid must be issued as an electronic prescription; and 2) provide for a one-year from the requirement if the practitioner can demonstrate economic hardship technological limitations or other exceptional circumstances beyond the practitioner’s control.
Chapters Affected Only affects this chapter.
Executive Branch Review This action will go through the normal Executive Branch Review process.
RIS Project Yes  [006085]
Associated Mandates Waiver for electronic prescribing
New Periodic Review This action will not be used to conduct a new periodic review.
 
Stages
Stages associated with this regulatory action.
Stage ID Stage Type Status
8714 Emergency/NOIRA Stage complete. Emergency regulation superseded by final permanent regulation.
8840 Proposed Stage complete. Comment period ended 11/13/2020.
9156 Final Stage complete. This regulation became effective on 06/09/2021.
 
Contact Information
Name / Title: Erin Barrett  / Director of Legislative and Regulatory Affairs
Address: Perimeter Center
9960 Mayland Drive, Suite 300
Henrico, VA 23233
Email Address: erin.barrett@dhp.virginia.gov
Phone: (804)367-4688    FAX: (804)915-0382    TDD: ()-

This person is the primary contact for this agency.